Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Real-World Evidence of SUL-DUR on Special Populations with CRAB Infection
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer
    Release Date:
    Partner:

    NCCN

    Review Process: Expert Review Panel
    Research Oncology All, USA
    Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    NSCLC – Current Practice Considerations
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom
    Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay
    Addressing Health Disparities in Inflammatory Bowel Disease
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology USA
    Enduring SpA Programs
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Atopic Dermatitis Patient Education
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Knowledge Gaps in Updated Pneumococcal Immunization Recommendations
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Prostate Cancer Disparities Project
    Release Date:
    Partner:

    American Cancer Society

    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All